🔴 Decoy Therapeutics is trading 10.4% down today with no confirmed company-specific catalyst identified

Decoy Therapeutics is trading at $1.28, down 10.44%, with no confirmed company-specific catalyst for the October 13 decline.

• The report likewise cites no clear announcement explaining the move.
• Biotech-sector weakness may have contributed: XBI fell 2.01% during the session, but this does not establish the cause of Decoy Therapeutics’ larger drop.
• An October 7 prospectus covers resale of up to 2,368,868 shares issuable upon warrant exercise; it is prior context, not a confirmed catalyst.